Director: Zihai Li
Scientific Co-Director: Mark Rubinstein, PhD (impd@osumc.edu)
Co-Director of Clinical Research: Yoshi Koguchi, MD, PhD
The Immune Monitoring & Discovery Platform (IMDP) contains technologies and services that are integrated across Shared Resources (SR) and used by all OSUCCC Programs. The IMDP provides guidance on immune monitoring and discovery study design, implementation, troubleshooting and analysis. Not merely a standard service provider, the IMDP operates as a technological hub for innovative immuno-oncology (IO) research, paving the way for advanced immune phenotyping and functional analyses as well as multiplexed biomarker detection methods.
IMDP’s Specific Aims
- Provide cutting-edge IO focused technology that gives researchers a panoramic view of the immune system regarding cancer research and treatment.
- In concert with the PIIO’s Immuno-Informatics Group, provide data analytics for flow cytometry, mass cytometry, scRNA-seq, scATAC-seq, single-cell proteomics and genomics, bulk RNA-seq, ChIP-seq, ATAC-seq, cytokine data, and spatial imaging.
- Develop and maintain an IO Bank as a comprehensive platform for collecting and preserving fresh cells and tissue from IO trial patients and routine clinical care patients, all linked to clinical and research data in real time.
- Train investigators on advanced immune phenotyping and multiplex technologies and novel immunoassays development.
Contact IMDP
Biomedical Research Tower
460 W. 12th Ave.
Columbus, OH 43210
Phone: 614-685-0802